Further studies on the protein conjugation of hydroxamic acid bifunctional chelating agents: Group-specific conjugation at two different loci

Bioconjugate Chemistry

Volumn 10, Issue 1, 1999, Pages 18-23

  Safavy, Ahmad ^a,c   Khazaeli, M B ^b   Kirk, Marion ^a   Coward, Lori ^a   Buchsbaum, Donald J ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b University of Alabama at Birmingham   (United States)

^c WTI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDES; AMINO ACIDS; CHELATION; ESTERS; HYDROGENATION; KETONES; LIGANDS;

ACTIVATED ESTER; BIFUNCTIONAL CHELATING AGENT; HYDRAZONES; HYDROXAMIC ACIDS; IMMUNOREACTIVITIES; KETONE DERIVATIVE; PROTECTING GROUP; PROTEIN CONJUGATIONS; SPECIFIC CONJUGATIONS; TERT-BUTYL CARBAZATE;

MONOCLONAL ANTIBODIES;

EID: 0032944226     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc980045d     Document Type: Article

References (23)

1. Safavy, A., Khazaeli, M. B., and Buchsbaum, D. J. (1997) Synthesis of bombesin analogues for radiolabeling with Rhenium-188. Cancer 80 (Suppl.), 2354-2359.
2. Yarranton, G. (1997) Antibodies as carriers for drugs and radioisotopes. In Antibody Therapeutics (W. J. Harris and J. R. Adair, Eds.) pp 53-72, CRC Press, Boca Raton.
3. 99mTc labelings, and animal in vivo biodistributions of divalent monoclonal antibody fragments. Bioconjugate Chem. 7, 290-297.
4. 131I-labeled counterparts. Cancer Biother. Radiopharm. 11, 133-144.
5. Fischman, A. J., Babich, J. W., and Strauss, H. W. (1993) A ticket to ride: Peptide radiopharmaceuticals. J. Nucl. Med. 34, 2253-2263
6. 99mTc labeling of highly potent small peptides. Bioconjugate Chem. 8, 621-636.
7. Arano, Y., Wakisaka, K., Mukai, T., Uezono, T., Motonari, H., Akizawa, H., Kairiyama, C., Ohmomo, Y., Tanaka, C., Ishiyama, M., Sakahara, H., Konishi, J., and Yokoyama, A. (1996) Stability of a metabolizable ester bond in radioimmunoconjugates. Nucl. Med. Biol. 23, 129-136.
8. DeNardo, S. J., Zhong, G.-R., Salako, Q., Li, M., DeNardo, G. L., and Meares, C. F. (1995) Pharmacokinetics of chimeric L6 conjugated to indium-111-and yttrium-90-DOTA-peptide in tumor-bearing mice. J. Nucl. Med. 36, 829-836.
9. Ultee, M. E., Bridger, G. J., Abrams, M. J., Longley, C. B., Burton, C. A., Larsen, S. K., Henson, G. W., Padmanabhan, S., Gaul, F. E., and Schwartz, D. A. (1997) Tumor imaging with technetium-99m-labeled hydrazinonicotinamide-Fab′ conjugates. J. Nucl. Med. 38, 133-138.
10. Safavy, A., Buchsbaum, D. J., and Khazaeli, M. B. (1993) Synthesis of N-[tris[2-[[N-(benzyloxy)amino]carbonyl]ethyl]-methyl]succinamic acid, trisuccin. Hydroxamic acid derivatives as a new class of bifunctional chelating agents. Bioconjugate Chem. 4, 194-198.
11. Safavy, A., Sanders, A., Qin, H., and Buchsbaum, D. J. (1997) Conjugation of unprotected trisuccin, N-[tris[2[(N-hydroxyamino)carbonyl]ethyl]methyl]succinamic acid, to monoclonal antibody CC49 by an improved active ester protocol. Bioconjugate Chem. 8, 766-771.
12. Brinkley, M. (1993) A brief survey of methods for preparing protein conjugates with dyes, haptens, and cross-linking reagents. In Perspectives in Bioconjujate Chemistry (C. F. Meares, Ed.) pp 59-70, American Chemical Society, Washington, DC.
13. Tijsen, P., and Kurstack, E. (1984) Highly efficient and simple methods for the preparation of peroxidase and active peroxidase-antibody conjugates for immunoassays. Anal. Biochem. 136, 451-457.
14. Chamow, S. M., Kogan, T. P., Peers, D. H., Hastings, R. C., Byrn, R. A., and Ashkenazi, A. (1992) Conjugation of soluble CD4 without loss of biological activity via a novel carbohydrate-directed cross-linking reagent. J. Biol. Chem. 267, 15916-15922.
15. Rodwell, J. D., Alvarez, V. L., Lee, C., Lopes, A. D., Goers, J. W. F., King, H. D., Powsner, H. J., and McKern, T. J. (1986) Site specific covalent modification of monoclonal antibodies: In vitro and in vivo evaluations. Proc. Natl. Acad. Sci. U.S.A. 83, 2632-2636.
16. Nakane, P. K., and Kawaoi, A. (1974) Peroxidase-labeled antibody. A new method of conjugation. J. Histochem. Cytochem. 22, 1084-1091.
17. Muraro, R., Kuroki, M., Wunderlich, D., Poole, D. J., Colcher, D., Thor, A., Greiner, J. W., Simpson, J. F., Molinolo, A., Noguchi, P., and Schlom, J. (1988) Generation and characterization of B72.3 second generation monoclonal antibodies reactive with the tumor-associated glycoprotein 72 antigen. Cancer Res. 48, 4588-4596.
18. Fraker, P. J., and Speck, J. C. (1978) Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3α,6α-diphenylglycoluril. Biochem. Biophys. Res. Commun. 80, 849-857.
19. Bergeron, R. J., McManis, J. S., Phanstiel, O., IV, and Vinson, J. R. T. (1995) A versatile synthesis of deferrioxamine B. J. Org. Chem. 60, 109-114.
20. Shao, J., and Tam, J. P. (1995) Unprotected peptides as building blocks for the synthesis of peptide dendrimers with oxime, hydrazone, and thiazolidine linkages. J. Am. Chem. Soc. 117, 3893-3899.
21. Jentoft, N., and Dearborn, D. G. (1979) Labeling of proteins by reductive methylation using sodium cyanoborohydride. J. Biol. Chem. 254, 4359-4365.
22. Goding, J. W. (1986) Production and applications of monoclonal antibodies in cell biology, biochemistry and immunology. Monoclonal Antibodies: Principles and Practice, pp 5-58, Academic Press, Orlando.
23. Lindmo, T., Boven, E., Cuttitta, F., Fedorko, J., and Bunn, P. A., Jr. (1984) Determination of the immunoreactive fraction of radiolabeled monoclonal antibodies by linear extrapolation to binding at infinite antigen excess. J. Immunol. Methods. 72, 77-89.